NDC11 70842024001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70842-0240-01 | 70842-0240 |
| 70842-0240-1 | 70842-0240 |
| 70842-240-01 | 70842-240 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REZZAYO | REZAFUNGIN | Melinta Therapeutics, LLC | 90073508-6dca-4d27-aa5a-ed837737c35b | 2026-07-01 | Warnings, Adverse reactions | 70842-240-01 70842-240 70842024001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.